drugset
Drugs / donor derived cytomegalovirus specific T lymphocytes
last change Dec 2021 re-read 3 minutes ago

donor derived cytomegalovirus specific T lymphocytes

Developed for
cytomegalovirus infection
Investigated by
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai iCELL Biotechnology Co., Ltd

Trials 1

today NCT03004261 · Ph 4
20172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT03004261 Nov 2016 → Dec 2021 cytomegalovirus infection, hematologic disorder Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as donor derived cytomegalovirus specific T lymphocytes ClinicalTrials.gov intervention name — accepted as the source's own label NCT03004261 ↗
Route Intravenous “The donor derived CMV-CTL cells will be transfused into the patients' intravenous line.” NCT03004261 ↗